Professional Documents
Culture Documents
PII: S2666-2507(20)30718-5
DOI: https://doi.org/10.1016/j.xjtc.2020.11.023
Reference: XJTC 473
Please cite this article as: Cleveland Clinic COVID-19 Tracheostomy Working Group, Bribriesco AC,
Sudarshan M, Gillespie C, Bryson P, Hopkins B, Tanner D, Raja S, Ahmad U, Raymond D, Murthy SC,
COVID-19: Team preparation and approach to tracheostomy, JTCVS Techniques (2021), doi: https://
doi.org/10.1016/j.xjtc.2020.11.023.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
Copyright © 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association for
Thoracic Surgery
1 COVID-19: Team preparation and approach to tracheostomy
2 Guidelines & Recommendations from
3 Cleveland Clinic COVID-19 Tracheostomy Working Group
4 Alejandro C. Bribriesco1* MD, Monisha Sudarshan1* MD MPH, Colin Gillespie2 MD, Paul
5 Bryson3 MD, Brandon Hopkins3 MD, Donna Tanner4 RRT-ACCS, Siva Raja1 MD PhD, Usman
6 Ahmad1 MD, Daniel Raymond1 MD, Sudish C. Murthy1 MD PhD
7
8 Author Affiliations:
1
9 Department of Thoracic and Cardiovascular Surgery, Heart Vascular and Thoracic Institute,
of
10 Cleveland Clinic
ro
2
11 Section of Interventional Pulmonology, Respiratory Institute, Cleveland Clinic
3
12 Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic
-p
4
13 Department of Intensive Care and Resuscitation, Anesthesia Institute, Cleveland Clinic
re
14 *Both authors contributed equally
lP
15 Justification for more than 4 authors: Multidisciplinary team effort involving representatives
16 from key stakeholders of different specialties at Cleveland Clinic contributing to creation of
17 guidelines, recommendations and manuscript.
na
18
ur
23 Corresponding Author
24 Alejandro C. Bribriesco, MD
25 Cleveland Clinic; Department of Thoracic and Cardiovascular Surgery
26 9500 Euclid Ave / Mail Stop J4-1
27 Cleveland, OH 44195
28 Email: bribria@ccf.org
29
1
31
32 Central Picture
of
ro
-p
re
lP
na
33
ur
36
37 Central Message
38 Tracheostomy in COVID-19 patients is a necessary but high exposure risk procedure. A
39 multidisciplinary approach with use of simulation is invaluable for development of a safe and
40 efficient protocol.
41
2
42 Introduction
43 Tracheostomy has become a common surgical intervention performed on patients with severe
45 during the intervention is a serious concern for personnel involved both during and after tracheostomy
47 COVID-19 respiratory failure. We recognize that this process will vary based on institutional policy and
48 will evolve with further data on transmission and respiratory consequences of COVID-19.
of
49 The role and benefits of multidisciplinary team and simulation
ro
50
51
-p
As the COVID-19 crisis unfolded, virtual meetings were held to develop a unified institutional
55 Next, we performed high fidelity tracheostomy simulation in our lab to rehearse and fine-tune
ur
56 procedural details including proper donning and doffing of PPE (PAPRs). Based on our experience and
Jo
57 aligned with other groups2, we strongly recommend simulation when devising a COVID-19 tracheostomy
60 A dedicated multidisciplinary team evaluates the patient and employs a standardized pre-
61 tracheostomy checklist (Supplemental Table 2). As there is no current evidence to suggest early
62 tracheostomy (<7 days) or delayed tracheostomy (>2-3 weeks) is of particular benefit in this population,
63 we consider tracheostomy a minimum of 7 days after intubation and preferably after 10-14 days in order
64 to enter the convalescent phase of the disease, gain the benefits of the procedure and permit time for
65 prognostication of overall recovery. We do not advocate waiting until a repeat negative COVID-19 test,
3
66 as this could unnecessarily prolong time to tracheostomy given possibility of persistently positive test
67 (one series3 with median 20 days, longest 37 days) which likely represents continued non-infectious viral
68 shedding.4 In addition, we always advocate for maximum available PPE regardless of a negative
of
72 Our default location is bedside in ICU to minimize patient transport and exposure risk with the
ro
73 operating room utilized for particularly high risk cases. For bedside tracheostomies, an enclosed negative
74 pressure ICU room is preferred if available and logistically feasible. Our team favors percutaneous over
-p
75 the open technique with deference to operator preference and patient anatomy.
re
76 Tracheotomy details
lP
77 The type of tracheostomy appliance is largely based on the institutional preference and available
na
78 supply. Our group favors an appliance without inner cannula to mitigate exposure risk of inner cannula
ur
79 exchange. Step by step details of the tracheostomy procedure with modifications to minimize
81 In COVID-19 patients, we arrange all ventilator control and intravenous lines outside the room so
82 care can be delivered without repeatedly entering the space. The sterile tracheostomy tray is prepared out
84 A moist Kerlix roll is packed in the oropharynx to minimize aerosolization as the endotracheal
85 tube is withdrawn into the subglottis. This obviates the need for a protective box/tent. A disposable
86 bronchoscope is used to avoid exposure during cleaning and processing of a soiled bronchoscope.
87 The endotracheal tube is pulled back with cuff inflated into the subglottic position. Further
88 retraction can be facilitated by removing the minimal necessary amount of air from the cuff. After
4
89 guidewire insertion, we perform the remainder of the procedure under apnea and attempt to limit
91 Conclusion
93 clinical decision for an essential-elective procedure has been reimagined when the safety of more than
94 just the patient must be considered. The balance of anticipated benefits and risks for major stakeholders
95 (patient, health care system and HCW) will vary between different locations during various stages of the
of
96 COVID-19 pandemic as evidenced by a multitude of available guidelines 5 (Supplemental Table 3). A
ro
97 multi-disciplinary team is essential in developing a center-specific protocol for COVID-19 tracheostomy
98
-p
with an indispensable role for simulation and team rehearsal. This activity allows providers who may not
re
99 have previously worked together to pool shared experience and knowledge to develop a tailored, efficient
lP
100 and safe protocol. Following this protocol, our team has performed more than 20 percutaneous
101 tracheostomies (including 4 patients on ECMO) in the ICU without untoward patient events or evidence
na
102 of COVID-19 transmission to HCWs. It is through synergistic collaboration that the optimal delivery of
ur
104
5
105
106 References
107 1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease
108 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese
109 Center for Disease Control and Prevention. JAMA. 2020.
110 2. LoSavio PS, Eggerstedt M, Tajudeen BA, et al. Rapid implementation of COVID-19 tracheostomy
111 simulation training to increase surgeon safety and confidence. Am J Otolaryngol.
112 2020;41:102574.
113 3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with
114 COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
115 4. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. 2020.
116 5. Chiesa-Estomba CM, Lechien JR, Calvo-Henriquez C, et al. Systematic review of international
of
117 guidelines for tracheostomy in COVID-19 patients. Oral Oncol. 2020;108:104844.
ro
118
119 -p
re
lP
na
ur
Jo
6
120
of
Outside room: as needed
ro
ICU Respiratory Therapist (ventilator located outside room)
• Assist with ventilator including period of apnea
-p
Bedside / ICU RN (IV pumps outside room)
• Administer ordered/prescribed sedation and paralytics
re
• Adjust vasoactive drips as necessary and/or directed
Intensivist
lP
***Team members must coordinate on key signs to convey the following (since verbal communication
limited with PAPRs and two members will be inside room)
• Ventilator on (thumbs up)
ur
7
6. Preparation inside room
• Operator scrubs in and preps and drapes area
• Bronchoscopist positions patient neck in optimally in extension with roll support and
packs oropharynx with moist Kerlix roll (not gauze squares to avoid retention)
7. Visualized ETT withdrawal using controlled deflation of cuff over bronchoscope to subglottic
position
• Removal of minimal amount of air from cuff may likely be required to withdraw
ETT to level needed for appropriate visualization
8. Communication through visual cue that ventilation needs to be paused/apnea time starts
9. Insertion of angiocatheter once 1st tracheal ring identified
• Insertion between 1st-2nd or 2nd-3rd tracheal rings
• Serial dilation (Moist gauze available on field to cover neck stoma as needed)
of
• Insertion of tracheostomy
10. With tracheostomy in place immediately insert bronchoscopy into tracheostomy for
ro
confirmation that tip is above carina and no significant bleeding
11. Remove bronchoscope from tracheostomy immediately connect HME + in-line suctioning to
tracheostomy -p
12. Connect to ventilator. Hand signal to start ventilation
re
• Estimated apnea time <1min
13. After satisfied no issues with procedure remove endotracheal tube and place immediately
lP
124
125 *PPE: personal protective equipment
ur
8
139
140
141 Figure 1. Approaching tracheostomy insertion in the COVID-19 patient
of
ro
142
143
-p
re
lP
na
ur
Jo
9
144 Videos
145
146 Video 1 – COVID-19 Tracheostomy Simulation
147 Narrated and annotated video demonstrating our step-by-step approach to performing percutaneous
148 tracheostomy in COVD-19 patients using a high fidelity simulation model. (Length of movie: 9 min 9
149 sec)
of
ro
-p
re
lP
na
ur
Jo
10
Table 1. Step by Step Approach to Percutaneous Tracheostomy in COVID-19 patients
of
Bedside / ICU RN (IV pumps outside room)
• Administer ordered/prescribed sedation and paralytics
ro
• Adjust vasoactive drips as necessary and/or directed
Intensivist
• Ready to donn PPE and enter for assistance if required
-p
• Additional airway provider
• Additional medications for sedation, paralysis and hemodynamic support
re
***Team members must coordinate on key signs to convey the following (since verbal communication
limited with PAPRs and two members will be inside room)
lP
of
tracheostomy
12. Connect to ventilator. Hand signal to start ventilation
ro
• Estimated apnea time <1min
13. After satisfied no issues with procedure remove endotracheal tube and place immediately
into biohazard bag -p
14. Secure tracheostomy with sutures and strap per routine
re
15. Proper Doffing of PPE before existing
lP